Antineoplaston Therapy in Treating Patients With Cancer of the Small Intestine

Stopped early · Phase 2

Conditions studied: Small Intestine Cancer

In brief

Current therapies for Cancer of the Small Intestine provide very limited benefit to the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the treatment of Cancer of the Small Intestine. PURPOSE: This study is being performed to determine the effects (good and bad) that Antineoplaston therapy has on patients with Cancer of the Small Intestine.

Key facts

Study ID

NCT00003522

Run by

Burzynski Research Institute

People needed

1

Starts

1997-08-13

Expected to finish

1997-12-14

Last updated by the study team

2017-09-29

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Burzynski Clinic — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.